New drug stalls blood cancer for longer than current common treatment
6/01/2015
New data from the Phase III GADOLIN study demonstrated that Gazyvaro, in combination with bendamustine chemotherapy, followed by Gazyvaro alone, reduced the risk of disease worsening or death by...
Experimental drug discovery could eventually treat common blood cancer
6/01/2015
UCLA scientists have developed a new drug therapy to treat multiple myeloma, the second most common blood cancer in the United States.
Multimodality treatment for metastatic lung cancer that includes surgery may improve survival rates
6/01/2015
Patients diagnosed with an advanced form of metastatic non-small cell lung cancer (NSCLC) may benefit from surgical resection (removal of all or part of the lung) in combination with chemotherapy...
Exciting discovery could boost radiotherapy effect on several cancers
6/01/2015
Scientists discover that AKT inhibitors may boost the effectiveness of radiotherapy in a range of cancers with a fault in the p53 gene that causes cancer cells to keep growing.
Melanoma rates dramatically increasing in children and young adults
6/01/2015
The incidence of melanoma, a deadly form of skin cancer, has increased by more than 250% among children, adolescents and young adults since 1973, according to award-winning research to be presented...
New cancer cases rise globally, but death rates are declining in many countries
6/01/2015
New cases of virtually all types of cancer are rising in countries globally - regardless of income - but the death rates from cancer are falling in many countries, according to a new analysis of 28...
Spouses' mood may impact the well-being of cancer survivors
6/01/2015
Cancer survivors whose spouses reported depressed mood were more likely to be depressed after about a year.
Immunotherapy combo increases progression-free survival in advanced melanoma patients
6/01/2015
Phase III trial findings shed light on who will benefit most from combinationTreating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab (Opdivo™) and...
Immunotherapy drug improves survival for common form of lung cancer
6/01/2015
In a head-to-head clinical trial comparing standard chemotherapy with the immunotherapy drug nivolumab, researchers found that people with squamous-non-small cell lung cancer who received nivolumab...
RTOG 0537 shows acupuncture-like ENS may provide relief for radiation-induced dry mouth
6/01/2015
Phase III results evaluated ENS and current standard treatment, pilocarpinePhase III results of Radiation Therapy Oncology Group (RTOG) 0537 indicate that acupuncture-like, transcutaneous...